The pervasiveness of interleukin-1 in Alzheimer pathogenesis: a role for specific polymorphisms in disease risk
- 1 July 2000
- journal article
- review article
- Published by Elsevier in Experimental Gerontology
- Vol. 35 (4) , 481-487
- https://doi.org/10.1016/s0531-5565(00)00110-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Interleukin-1 Promotes Expression and Phosphorylation of Neurofilament and tau Proteins in VivoExperimental Neurology, 2000
- Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease ProgressionBrain Pathology, 1998
- Differential regulation of C3 gene expression in human astroglioma cells by interferon-γ and interleukin-1βNeuroscience Letters, 1995
- Microglial inter leukin‐1α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distributionNeuropathology and Applied Neurobiology, 1995
- S100β protein expression in Alzheimer disease: Potential role in the pathogenesis of neuritic plaquesJournal of Neuroscience Research, 1994
- A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitroEuropean Journal of Clinical Investigation, 1992
- Cytokine Regulation of Neuronal SurvivalJournal of Neurochemistry, 1992
- Increased S100β neurotrophic activity in Alzheimer's disease temporal lobeNeurobiology of Aging, 1992
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991
- Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndromeAnnals of Neurology, 1985